|
|
Volumn 474, Issue 7350 SUPPL., 2011, Pages
|
|
Therapeutics: New drugs hit the target
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABT 267;
ACH 1095;
ALPHA INTERFERON;
AZD 7295;
BI 201335;
BMS 650032;
BMS 791325;
BOCEPREVIR;
DANOPREVIR;
EDP 239;
GS 5885;
GS 9256;
GS 9451;
GSK 2336805;
IDX 380;
IDX 719;
MERICITABINE;
MK 5172;
PEGINTERFERON ALPHA;
PPI 1301;
PPI 437;
PPI 461;
PPI 668;
PPI 833;
PROTEINASE INHIBITOR;
RIBAVIRIN;
TELAPREVIR;
TMC 435350;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VANIPREVIR;
DISEASE TREATMENT;
DRUG DEVELOPMENT;
ENZYME ACTIVITY;
HEPATITIS;
INHIBITOR;
MEDICINE;
PATHOLOGY;
PHARMACEUTICAL INDUSTRY;
PROTEIN;
RESEARCH AND DEVELOPMENT;
SYMPTOM;
ANEMIA;
ANTIVIRAL ACTIVITY;
ANTIVIRAL RESISTANCE;
ARTICLE;
DEPRESSION;
DRUG APPROVAL;
DRUG ERUPTION;
DRUG MANUFACTURE;
DRUG TARGETING;
DRUG WITHDRAWAL;
FLU LIKE SYNDROME;
HEPATITIS C;
HUMAN;
PRIORITY JOURNAL;
TASTE DISORDER;
ANTIVIRAL AGENTS;
CLINICAL TRIALS, PHASE III AS TOPIC;
HEPACIVIRUS;
HEPATITIS C;
HETEROCYCLIC COMPOUNDS, 3-RING;
HUMANS;
INTERFERON-ALPHA;
OLIGOPEPTIDES;
PROLINE;
RIBAVIRIN;
SULFONAMIDES;
|
|
EID: 79958829910
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/474S5a Document Type: Article |
|
Times cited : (54)
|
|
References (0)
|
